Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients

BACKGROUND: Bezlotoxumab significantly reduces the incidence of recurrent Clostridioides difficile infection (CDI); however, limited data are available in solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. METHODS: We conducted a single-center retrospective analysis com...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Open Forum Infect Dis
Prif Awduron: Johnson, Tanner M, Howard, Amanda H, Miller, Matthew A, Allen, Lorna L, Huang, Misha, Molina, Kyle C, Bajrovic, Valida
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2021
Pynciau:
Major Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274359/
https://ncbi.nlm.nih.gov/pubmed/34262988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab294
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg